B7-H3 mRNA and protein are overexpressed in the majority of human cancers53,54, and clinical trials of anti-B7-H3 antibody are underway for melanoma, squamous cell cancer of the head and neck (SCCHN), and non-small cell lung cancer (NSCLC). Here, CD276 is linked to non-small cell lung carcinoma.